Cohort study reveals improved survival with surveillance in hepatocellular carcinoma, indicating greater benefits for viral etiologies compared to nonviral liver diseases.
This cohort study of 1185 participants with HCC found that HCC surveillance was associated with improved survival. This survival benefit was more prominent for people with HBV-associated and HCV-associated HCC. The survival benefit of surveillance was less consistent for people with MASLD-associated or alcohol-associated HCC, which may have been related to the relatively modest sample size in the nonviral groups.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: